Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Clinical Studies: SOP for Informed Consent Process

Posted on By

Standard Operating Procedure for Obtaining Informed Consent in Clinical Research

Purpose

The purpose of this SOP is to establish the process for obtaining informed consent from participants in clinical trials and clinical studies. This SOP ensures that participants are provided with all necessary information to make an informed decision about their participation.

Scope

This SOP applies to all personnel involved in obtaining informed consent from study participants, including principal investigators, clinical research coordinators, and other research staff.

Responsibilities

  • Principal Investigator (PI): Ensures the informed consent process is conducted according to ethical and regulatory standards.
  • Clinical Research Coordinators: Conduct the informed consent discussions and obtain signed consent forms.
  • Study Team: Assists in providing information and answering participants’ questions.
See also  SOP for Use of Electronic Systems and eCRFs

Procedure

  • Preparation:
    • Prepare the informed consent form (ICF) according to study protocol and regulatory guidelines.
    • Review the ICF with the study team to ensure it accurately reflects the study’s risks and benefits.
    • Ensure the ICF is written in clear, non-technical language and is available in the participant’s preferred language.
  • Participant Information:
    • Meet with the participant in a private and quiet setting.
    • Provide the ICF and give the participant ample time to read it.
    • Explain the purpose, procedures, risks, benefits, and alternatives of the study.
    • Allow the participant to ask questions and provide answers to their satisfaction.
  • Obtaining Consent:
    • Ensure the participant understands the
study and their rights.
  • Obtain the participant’s signature on the ICF, along with the signature of a witness if required.
  • Provide a copy of the signed ICF to the participant.
  • Documentation:
    • Document the consent process, including the date, time, and details of the discussion.
    • File the original signed ICF in the participant’s study record.
  • Ongoing Consent:
    • Monitor the participant’s understanding and willingness to continue in the study throughout its duration.
    • Obtain re-consent if there are significant changes to the study.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator
    • ICF: Informed Consent Form

    Documents

    • Informed consent forms (draft and final versions)
    • Participant information sheets
    • Documentation of informed consent discussions
    • Signed informed consent forms

    References

    • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)
    • Ethics committee regulations
    • Institutional policies and procedures

    SOP Version

    Version: 1.0

    See also  SOP for Archiving and Long-Term Storage of Records
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs Data management SOPs Electronic systems validation, clinical trials, Conflict of interest management, Data collection methods, eCRF validation, Electronic record-keeping guidelines, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: SOP for Study Protocol Development and Approval
    Next Post: SOP for Site Selection and Initiation

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version